Induction of autocrine factor inhibiting cell motility from murine B16- BL6 melanoma cells by α-melanocyte stimulating hormone

International Journal of Cancer

Volumn 80, Issue 6, 1999, Pages 889-895

  Murata, Jun ^a   Ayukawa, Koichi ^a   Ogasawara, Masaru ^a   Watanabe, Hideomi ^b   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; AUTOCRINE MOTILITY FACTOR; CYCLIC AMP; CYCLOHEXIMIDE; FORSKOLIN;

ANIMAL CELL; ARTICLE; CANCER INFILTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; ENZYME INDUCTION; MEDIATOR RELEASE; MELANOMA; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REACTION ANALYSIS; REGULATORY MECHANISM;

ADENYLATE CYCLASE; ALPHA-MSH; ANIMALS; BIOLOGICAL FACTORS; CELL MOVEMENT; CULTURE MEDIA, CONDITIONED; CYCLIC AMP; CYCLOHEXIMIDE; DEPRESSION, CHEMICAL; DIDEOXYADENOSINE; FORSKOLIN; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM PROTEINS; PROTEIN DENATURATION; PROTEIN SYNTHESIS INHIBITORS; SECOND MESSENGER SYSTEMS; TUMOR CELLS, CULTURED;

EID: 0033559572     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990315)80:6<889::AID-IJC15>3.0.CO;2-M     Document Type: Article

References (32)

1. BROUTY-BOYÉ, D. and ZETTER, B.R., Inhibition of cell motility by interferon. Science, 208, 516-518 (1980).
2. CATANIA, A. and LIPTON, J.M., α-Melanocyte-stimulating hormone peptides in host responses. Ann. N.Y. Acad. Sci., 680, 412-423 (1993).
3. CATANIA, A. RAJORA, N., CAPSONI, F., STAR, R.A. and LIPTON, J.M., The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides, 17, 675-679 (1996).
4. DESCHODT-LANCKMAN, M., VANNESTE, Y. LOIR, B., MICHEL, A., LIBERT, A., GHANEM, G. and LEJEUNE, F., Degradation of alpha-melanocyte stimulating hormone (alpha-MSH) by CALLA/endopeptidase 24.11 expressed by human melanoma cells in culture. Int. J. Cancer, 46, 1124-1130 (1990).
5. GREY, A.-M., SCHOR, A.M., RUSHTON, G., ELLIS, I. and SCHOR, S.L., Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc. nat. Acad. Sci. (Wash.), 86, 2438-2442 (1989).
6. HASKELL-LUEVANO, C., MIWA H., DICKINSON, C. HRUBY, V.J., YAMADA, T. and GANTZ, I., Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R. Biochem. biophys. Res. Comm., 204, 1137-1142 (1994).
7. HISCOX, S., HALLETT, M.B., PUNTIS, M.C.A. and JIANG, W.G., Inhibition of cancer cell motility and invasion by interleukin-12. Clin. exp. Metastasis, 13, 396-404 (1995).
8. HOSAKA, S., SUZUKI, M., GOTO, M. and SATO, H., Motility of rat ascites hepatoma cells, with reherence to malignant characteristics in cancer metastasis. Gann. 69, 273-276 (1978).
9. ISOAI, A., GIGA-HAMA, Y., SHINKAI, K., MUKAI, M., AKEDO, H. and KUMAGAI, H., Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells. Cancer Res., 52, 1422-1426 (1992).
10. LIOTTA, L.A., MANDLER, R., MURANO, G., KATZ., D.A., GORDON, R.K., CHIANG, P.K. and SCHIFFMANN, E., Tumor cell autocrine motility factor. Proc. nat. Acad. Sci. (Wash.), 83, 3302-3306 (1986).
11. LIPTON, J.M., Neuropeptide alpha-melanocyte stimulating hormone in control of fever, the acute phase response and inflamation. In E.J. Goetzl and N.H. Spector (eds.), Neuroimmune networks: physiology and disease, pp. 243-250, A.R. Liss, New York (1989).
12. LIPTON, J.M. and CATANIA, A., Anti-inflammatory actions of the neuroimmunomodulator α-MSH. Immunol. Today, 18, 140-145 (1997).
13. MOHLER, J.L., BAKEWELL, W.E., SHARIEF, Y. COLEMAN, W.B., CHAY, C.H., SILVERS, S.M. and SMITH, G.J., Detection of candidates for cancer cell motility inhibitory protein in the Dunning adenocarcinoma model. Clin. exp. Metastasis, 13, 474-480 (1995).
14. MOHLER, J.L., PARTIN, A.W. and COFFEY, D.S., Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R0327 prostalic adenocarcinoma model. J. Urol., 138, 168-170 (1987).
15. MURATA, J., AYUKAWA, K., OGASAWARA, M., FIJII, H. and SAIKI, I., α-Melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells. Invasion Metastasis, 17, 82-93 (1997).
16. MURATA, J., LEE, H.-Y., CLAIR, T., KRUTZSCH, H.C., ARESTAD, A., SOBEL, M.E., LIOTTA, L.A. and STRACKE, M.L., cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J. biol. Chem., 269, 30479-30484 (1994).
17. MURATA, J., SAIKI, I., YONEDA, J. and AZUMA, I., Differences in chemotaxis to fibronectin in weakly and highly metastatic tumor cells. Jpn. J. Cancer Res., 83, 1327-1333 (1992).
18. ORR, F.W., VARANI, J., DELIKATNY, J., JAIN, N. and WARD, P.A., Comparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy. Amer. J. Pathol. 102, 160-167 (1981).
19. PARTIN, N.W., ISAACS, J.T., TRIEGER, B. and COFFEY, D.S., Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with V-Harvey-ras oncogene. Cancer Res., 48, 6050-6053 (1988).
20. PAWELEK, J.M., Studies on the Cloudman melanoma cell lines as a model for the action of MSH. Yale J. Biol. Med., 58, 571-578 (1985).
21. POSTE, G. and FIDLER, I.J., The pathogenesis of cancer metastasis. Nature (Lond.), 283, 139-146 (1980).
22. RAZ, A. and BEN-ZE'EV, A., Cell contact and architecture of malignant cells and their relationship to metastasis. Cancer Metastasis Rev., 6, 3-21 (1987).
23. SADAHIRA, Y., RUAN, F., HAKOMORI, S. and IGARASHI, Y., Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Proc. natl. Acad. Sci. (Wash.), 89, 9686-9690 (1992).
24. SCHIOTH, H.B., MUCENIECE, R., WIKBERG, J.E. and CHHAJLANI, V., Characterization of melanocortin receptor subtypes by radioligand binding analysis. Europ. J. Pharmacol., 288, 311-317 (1995).
25. STOKER, M. and GHERARDI, E., Regulation of cell movement: the motogenic cytokines. Biochim. Biophys. Acta. 1072, 81-102 (1991).
26. STRACKE, M.L., KRUTZSCH, H.C., UNSWORTH, E.J., ARESTAD, A., CIOCE, V., SCHIFFMANN, E. and LIOTTA, L.A., identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. biol. Chem., 267, 2524-2529 (1992).
27. STRACKE, M.L., MURATA, J., AZNAVOORIAN, S. and LIOTTA, L.A., The role of the extracellular matrix in tumor cell metastasis. In vivo, 8, 49-58 (1994).
28. TURLEY, E.A., Molecular mechanisms of cell motility. Cancer Metastasis Rev., 11, 1-3 (1992).
29. VERHAAGEN, J., EDWARDS, P.M., JENNEKENS, F.G.I., SCHOTMAN, P. and GISPEN, W.H., α-Melanocyte-stimulating hormone stimulates the outgrowth of myelinated nerve fibers after peripheral nerve crush. Exp. Neurol., 92, 451-454 (1986).
30. WANG, M. and STEARNS, M., Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in SCID mice. Differentiation, 48, 115-125 (1991).
31. WATANABE, H., KANBE, K. and CHIGIRA, M., Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma. Clin. exp. Metastasis, 12, 155-163 (1994).
32. WATANABE, H., TAKEHARA, K., DATE, M., SHINOZAKI, T. and RAZ, A., Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res., 56, 2960-2963 (1996).